For further detail, please contact Mette Bach Larsen, e

Screening
mammography
n (%)
Ductalt carcinoma
Abnormal screein situ
ning result
n (% (95 % CI))
n (% (95 % CI))
Breast cancer
n (% (95 %
CI))
20-49 år
409 (51.3)
18 (4.4 (2.6-6.9))
1 (0.2 (0.0-1.4))
1 (0.2 (0.0-1.4))
50-69 år
341 (42.8)
26 (7.6 (5.0-11.0))
0 (0.0 (0.0-1.1))
5 (1.5 (0.5-3.4))
47 (5.9)
6 (12.8 (4.8-25.7))
0 (0.0 (0.0-7.5))
2 (4.3 (0.5-14.5))
797 (100)
50 (6.3 (4.7-8.2))
1 (0.1 (0.0-0.7))
1.0 (0.4-2.0))
≥ 70 år
Alle
Breast cancer <
Normal screening
12 months after
mammography
screening
Breast cancer ≥
12 months after
screening
Total
20-49 år
409 (51.3)
18 (4.4 (2.6-6.9))
1 (0.2 (0.0-1.4))
1 (0.2 (0.0-1.4))
50-69 år
341 (42.8)
26 (7.6 (5.0-11.0))
0 (0.0 (0.0-1.1))
5 (1.5 (0.5-3.4))
47 (5.9)
6 (12,8 (4.8-25.7))
0 (0.0 (0.0-7.5))
2 (4.3 (0.5-14.5))
797 (100)
50 (6.3 (4.7-8.2))
1 (0.1 (0.0-0.7))
8 (1.0 (0.4-2.0))
≥ 70 år
Alle
For further detail, please contact Mette Bach Larsen, e-mail: [email protected]